Thursday, 28 February 2013
European Medicines Agency recommends extending the therapeutic indication of Cervarix
On 21 February 2013, the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Cervarix. The marketing authorisation holder for this medicinal product is GlaxoSmithKline Biologicals S.A. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment